Tag: Newron Pharmaceuticals

March 22, 2017 Off

FDA OK’s Parkinson’s disease drug

By Dino Mustafić

The U.S. Food and Drug Administration has approved Newron Pharmaceuticals’s Xadago (safinamide) tablets as an add-on treatment for patients with Parkinson’s disease who are currently taking levodopa/carbidopa.